Christian Müller has an extensive career in the pharmaceutical industry with a focus on packaging and serialization. Since 2020, he has been serving as a Global Serialization Expert & Project Manager at Roche AG in Basel, responsible for worldwide serialization tracking and project oversight. Prior to this, from 2015 to 2020, Christian held the position of CMO Packaging & Serialization Manager at Basilea Pharma AG in Basel. Preceding that, from 2002 to 2015, he showcased exceptional leadership as Head of Packaging at Siegfried Generics & Arena Zofingen AG. Christian's journey in the industry began in 2001 when he worked as an Assistant Head of Packaging at Siegfried Generics AG in Zofingen until July 2002. Earlier, he served as Head of Production at Siegfried Agro AG in Zofingen from April 2000 to October 2001, overseeing production processes. Before that, from August 1995 to April 2000, he was the Head of Production Solid Dos. Forms at Pfizer AG in Freiburg, contributing to solid dosage form production. Christian started his professional career as a Production Worker in Coated-Tubes Production at Henning Berlin in 1990 and, prior to that, worked as a Chemical Worker at Guhl Kosmetik AG in Berlin from 1988 to 1990. His diverse roles demonstrate his dedication and valuable contributions to the pharmaceutical industry's packaging and serialization sector.

I love to work in a challenging environment and I am passionate to work in organizing and streamlining complex processes like serialization. I am keen to develop new solutions for my company and curios to learn new stuff on a daily base. I appreciate the challenges and responsibilities that came along with my current global role as a global serialization expert for Roche. I love working with different teams and cultures across the world and have the opportunity to develop innovative solutions to improve patient safety all over the world. Fighting against the fakes & counterfeits is my daily mission.
I feel that my work is meaningful to the society, the healthcare community and to all patients, not only to our patients and what I do makes a difference and increases patient safety around the world. This drives my motivation to keep doing it even though there may be times when the going gets tough.

The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.